Page 128 - The diagnostic work-up of women with postmenopausal bleeding
P. 128
Chapter 6
References
1. Astrup K, Olivarius Nde F. Frequency of spontaneously occurring postmenopausal bleeding in the general population. Acta Obstet Gynecol Scand 2004 Feb;83(2):203-207.
2. Dijkhuizen FP, Brolmann HA, Potters AE, Bongers MY, Heinz AP. The accuracy of transvaginal ultrasonography in the diagnosis of endometrial abnormalities. Obstet Gynecol 1996 Mar ;87(3):345-349.
3. Emanuel M,Verdel M,Wamsteker K, Lammes F.An audit of true prevalence of intrauterine pathology: the hysteroscopic findings, controled for patient selection in 1202 patients with abnormal uterine bleeding. Gynecol Endosc 1995(4):237-241.
4. Smith-Bindman R, Kerlikowske K, Feldstein VA, Subak L, Scheidler J, Segal M, et al. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA 1998 Nov 4;280(17):1510- 1517.
5. Tabor A, Watt HC, Wald NJ. Endometrial thickness as a test for endometrial cancer in women with postmenopausal vaginal bleeding. Obstet Gynecol 2002 Apr ;99(4):663-670.
6. Timmermans AO, Brent C., Khan KS, Bachmann LM, Epstein EC, T., Justin Gupta JK, Bakour SH, et al. EndometrialThickness Measurement for Detecting Endometrial Cancer inWomenWith Postmenopausal Bleeding: A Systematic Review and Meta-Analysis. Obstetrics & Gynaecology 2010 July;116(1):160-167.
7. van Hanegem N, Breijer MC, Khan KS, Clark TJ, Burger MP, Mol BW, et al. Diagnostic evaluation of the endometrium in postmenopausal bleeding: an evidence-based approach. Maturitas 2011 Feb;68(2):155- 164.
8. Dutch Society of Obstetrics and Gynaecology (NVOG). Diagnostics in abnormal vaginal blood loss in the postmenopausal period. 2003.
9. Epstein E. Management of postmenopausal bleeding in Sweden: a need for increased use of hydrosonography and hysteroscopy. Acta Obstet Gynecol Scand 2004 Jan;83(1):89-95.
10. American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 426: The role of transvaginal ultrasonography in the evaluation of postmenopausal bleeding. Obstet Gynecol 2009 Feb;113(2 Pt 1):462-464.
11. ClarkTJ.Accuracy of Hysteroscopy in the Diagnosis of Endometrial Cancer and Hyperplasia:A Systematic Quantitative Review. JAMA:The Journal of the American Medical Association 2002;288(13):1610-1621.
12. de Kroon CD, de Bock GH, Dieben SW, Jansen FW. Saline contrast hysterosonography in abnormal uterine bleeding: a systematic review and meta-analysis. BJOG 2003 Oct;110(10):938-947.
13. Dijkhuizen FP, Mol BW, Brolmann HA, Heintz AP.The accuracy of endometrial sampling in the diagnosis of patients with endometrial cancer and hyperplasia: a meta-analysis. Cancer 2000 Oct 15;89(8):1765-1772.
14. Clark TJ, Mann CH, Shah N, Khan KS, Song F, Gupta JK. Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial cancer: a systematic quantitative review. BJOG 2002 Mar;109(3):313-321.
15. Clark TJ, Mann CH, Shah N, Khan KS, Song F, Gupta JK. Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial hyperplasia. Acta Obstet Gynecol Scand 2001 Sep;80(9):784-793.
16. van Hanegem N and Breijer MC, Slockers SA, Zafarmand MH, Geomini PMAJ, Catshoek R, Pijnenborg JMA, et al. Diagnostic work-up for postmenopausal bleeding: a randomised controlled trial. Submitted 2015.
17. Dutch Consortium for Women’s Health. Effectiveness of saline-infused sonography and hysteroscopy in the work-up for postmenopausal bleeding. 2008; www.studies-obsgyn.nl/pompoen/ (01-04-2015).
18. Hakkaart-van Roijen L, Tan SS, Bouwmans CAM. Handleiding voor kostenonderzoek: Methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg. Geactualiseerde versie 2010. [Dutch manual for costing in economic evaluations]. Diemen: College voor zorgverzekeringen (CVZ); 2011.
19. Statistics Netherlands (2012) Voorburg/Heerlen: Centraal Bureau voor de Statistiek (CBS).
20. Black WC: The CE plane: a graphic representation of cost-effectiveness. Med Decis Making 1990; 10(3):212-214.
21. Fenwick E, O’Brien BJ, Briggs A: Cost-effectiveness acceptability curves-facts, fallacies and frequently asked questions. Health Econ 2004; 13(5):405-415.
126
